Tag: biomedical

  • Medical Industry Payment Recipients Identified

    5 January 2016. An analysis of industry payments to physicians shows cardiovascular specialists and neurosurgeons were the specialties most likely to receive payments from pharmaceutical and medical device companies. The findings appear in this month’s issue of the journal Mayo Clinic Proceedings. The research team from University of California in San Diego, led by radiation…

  • Clinical Trials to Test Artificial Pancreas

    4 January 2016. Two new clinical trials are planned to test a smartphone-based closed-loop artificial pancreas system for people with type 1 diabetes. The system is developed by teams at University of Virginia in Charlottesville and Harvard University, and licensed for commercial development by TypeZero LLC, also in Charlottesville. The trials are funded by a…

  • Patent Awarded for Liquid Biopsy Technology

    4 January 2016. A new U.S. patent was awarded for a technology that detects a broad range of cancers in blood, rather than taking tissue samples for analysis, usually requiring surgery. Jacob Micallef, chief scientist at VolitionRx, a developer of cancer diagnostics in Namur, Belgium, received patent number 9,222,937 on 29 December 2015 from the…

  • Autism App Adapts Facial Analysis Software

    31 December 2015. A research team at Duke University is using facial analysis software routines developed for the U.S. Navy in building a smartphone app to screen for autism. The Duke team, led by engineering professor Guillermo Sapiro, adapted algorithms designed for the Office of Naval Research to analyze emotions displayed through facial expressions. Sapiro…

  • Trial Underway Testing Preterm Respiratory Treatment

    30 December 2015. A clinical trial testing new treatment methods for a common respiratory disorder faced by preterm babies began enrolling patients. The trial is testing an aerosol-delivered surfactant, a wetting agent applied to the lungs of babies born prematurely without natural surfactants to keep open air sacs in lungs, made by Discovery Laboratories a biotechnology…

  • Cancer Genome Data Visualization Tool Developed

    29 December 2015. A bioinformatics team at St. Jude Children’s Research Hospital created a Web-based system that illustrates genetic mutations behind pediatric cancers. The software and database in ProteinPaint, as the system is called, are described in a letter in today’s issue of the journal Nature Genetics (paid subscription required). The team led by Jinghui…

  • Human Cornea Cells Derived from Stem Cells

    28 December 2015. A biotechnology company designed a process for generating human cornea cells from embryonic stem cells, without a donated cornea, the current replacement therapy. The team from Ocata Therapeutics Inc. led by Robert Lanza, the company’s chief scientist, published its proof-of-concept findings last week in the journal PLoS One. Lanza and colleagues —…

  • Trial Shows Vaccine Protects Against Stem Cell Complications

    24 December 2015. An early-stage clinical trial indicates a vaccine protects against complications from stem cell transplants used to treat blood-related cancers. Results of the trial conducted by City of Hope medical center in Duarte, California that developed the vaccine appear online in the journal The Lancet Haematology (paid subscription required), and were discussed earlier…

  • Bioactive Glass Reduces Decay in Tooth Cavity Fillings

    23 December 2015. An engineering group at Oregon State University adapted a type of glass material that in lab models slows the decay in teeth with composite cavity fillings. The team led by materials engineering professor Jamie Kruzic published its findings in the January 2016 issue of the journal Dental Materials. Kruzic, with colleagues from…

  • Start-Up Licenses Founder’s Research for Resistant Bacteria

    22 December 2015. A biotechnology company spun-off from University of California in San Diego is licensing technology from the university to develop treatments for bacterial infections now becoming resistant to conventional antibiotics. Financial terms of the licensing agreement between UC-San Diego and Forge Therapeutics were not disclosed. Forge Therapeutics, also in San Diego, is licensing…